2013•Journal of Henan Medical College for Staff and WorkersRequires access

Clinical Study on the Treatment of Essential Hypertension by Irbesartan and Levamlodipine

LI Qing-guang

Abstract

Objective To observe the treatment effects of hypertension with Irbesartan and Levamlodioine.Methods 86 patients were randomly divided into treatment group treated by Irastan and Levamlodioine and control group treated by Irastan.Results The effective rates in treatment group was 92.3% and the effective rates in the other group was 74.7%.The difference between these two groups was statistically significant(P0.05).Conclusion The clinical efficacy of Irbesartan and Levamlodioine is better than that of Irbesartan.

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Irbesartan, Medicine, Clinical efficacy, Empagliflozin, Internal medicine, Treatment and control groups, Essential hypertension, Significant difference